tiprankstipranks
Revive Therapeutics Ltd (TSE:RVV)
:RVV
Canadian Market

Revive Therapeutics (RVV) Income Statement

Compare
127 Followers

Revive Therapeutics Income Statement

Last quarter (Q1 2024), Revive Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Revive Therapeutics's net income was C$-472.51K. See Revive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -328.00C$ -434.00C$ -578.00C$ -775.00C$ -28.27K
Operating Expenses
C$ 3.29MC$ 5.52MC$ 17.83MC$ 18.59MC$ 3.68M
Depreciation and Amortization
C$ 328.00C$ 434.00C$ 578.00C$ 775.00C$ 28.27K
EBITDA
C$ -5.60MC$ -5.52MC$ -17.74MC$ -18.57MC$ -5.26M
Operating Income
C$ -3.29MC$ -5.41MC$ -17.72MC$ -18.50MC$ -4.84M
Other Income/Expenses
C$ -2.33MC$ -796.15KC$ 32.46KC$ -1.55MC$ -1.72M
Pretax Income
C$ -5.62MC$ -6.32MC$ -17.81MC$ -20.12MC$ -5.38M
Net Income
C$ -5.62MC$ -6.32MC$ -17.83MC$ -20.20MC$ -4.27M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.01C$ -0.02C$ -0.06C$ -0.08C$ -0.04
Diluted EPS
C$ -0.01C$ -0.02C$ -0.06C$ -0.08C$ -0.04
Weighted Average Shares Outstanding
380.48M 339.37M 319.76M 267.49M 106.88M
Weighted Average Shares Outstanding (Diluted)
380.48M 339.37M 319.76M 267.49M 106.88M
Currency in CAD

Revive Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis